High expression of SCHLAP1 in primary prostate cancer is an independent predictor of biochemical recurrence, despite substantial heterogeneity.

MLA

Kidd, Susanne G., et al. “High Expression of SCHLAP1 in Primary Prostate Cancer Is an Independent Predictor of Biochemical Recurrence, despite Substantial Heterogeneity.” Neoplasia (New York, N.Y.), vol. 23, no. 6, June 2021, pp. 634–41. EBSCOhost, https://doi.org/10.1016/j.neo.2021.05.012.

APA

Kidd, S. G., Carm, K. T., Bogaard, M., Olsen, L. G., Bakken, A. C., Løvf, M., Lothe, R. A., Axcrona, K., Axcrona, U., & Skotheim, R. I. (2021). High expression of SCHLAP1 in primary prostate cancer is an independent predictor of biochemical recurrence, despite substantial heterogeneity. Neoplasia (New York, N.Y.), 23(6), 634–641. https://doi.org/10.1016/j.neo.2021.05.012

Chicago

Kidd, Susanne G, Kristina T Carm, Mari Bogaard, Linn Guro Olsen, Anne Cathrine Bakken, Marthe Løvf, Ragnhild A Lothe, Karol Axcrona, Ulrika Axcrona, and Rolf I Skotheim. 2021. “High Expression of SCHLAP1 in Primary Prostate Cancer Is an Independent Predictor of Biochemical Recurrence, despite Substantial Heterogeneity.” Neoplasia (New York, N.Y.) 23 (6): 634–41. doi:10.1016/j.neo.2021.05.012.